Mirati Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Mirati Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 83% to $12,436,000. Profit margin reached -5957%. Total operating expenses were $771,425,000.
Profit Margin
| 2013 | 0 | -52.87M | |
|---|---|---|---|
| 2014 | 0 | -43.68M | |
| 2015 | 0 | -64.50M | |
| 2016 | 0 | -83.14M | |
| 2017 | 0 | -70.48M | |
| 2018 | 12.92M | -98.41M | -761.4% |
| 2019 | 3.33M | -212.59M | -6374.72% |
| 2020 | 13.39M | -357.42M | -2667.76% |
| 2021 | 72.09M | -581.78M | -807% |
| 2022 | 12.43M | -740.86M | -5957.44% |
MRTX Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 12.43M | 72.09M | 13.39M | 3.33M | 12.92M | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 600K | 508.59M | 299.34M | 182.86M | 93.87M | 58.08M | 68.48M | 0 | 0 | 0 |
Gross profit | 11.83M | -436.50M | -285.95M | -179.53M | -80.94M | -58.08M | -68.48M | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 531.62M | 508.59M | 299.34M | 182.86M | 93.87M | 58.08M | 68.48M | 48.95M | 26.07M | 19.79M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 771.42M | 645.27M | 382.76M | 225.43M | 115.55M | 71.53M | 83.77M | 64.71M | 38.77M | 30.94M |
Operating income | -759.58M | -573.18M | -369.36M | -222.10M | -102.62M | -71.53M | -83.77M | -64.71M | -39.10M | -31.96M |
Other income (expenses), net | 19.23M | -5.30M | 11.42M | 8.84M | 4.20M | 1.10M | 661K | 170K | -4.92M | -22.14M |
Income before tax | -740.35M | -578.48M | -357.93M | -213.25M | -98.41M | -70.43M | -83.11M | -64.54M | -43.69M | -52.88M |
Income tax expense | 508K | 3.29M | -511K | -659K | 4.20M | -130K | -155K | -249K | 121K | -23K |
Net income | -740.86M | -581.78M | -357.42M | -212.59M | -98.41M | -70.48M | -83.14M | -64.50M | -43.68M | -52.87M |
Earnings per share | ||||||||||
Basic EPS | -13.18 | -11.21 | -7.94 | -5.67 | -3.19 | -2.79 | -4.2 | -3.82 | -3.24 | -4.78 |
Diluted EPS | -13.18 | -11.21 | -7.94 | -5.67 | -3.19 | -2.79 | -4.2 | -3.82 | -3.24 | -4.78 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |